Elihu Estey
伊利胡·埃斯蒂
MD
Professor of Medicine, Division of Hematology血液科医学教授
👥Biography 个人简介
Pioneer in AML therapy with decades of landmark clinical research at MD Anderson and Fred Hutchinson. Championed low-intensity treatment regimens for elderly AML patients, fundamentally reshaping standard-of-care decisions for older adults with this disease.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Low-Intensity AML Therapy
Established evidence base for hypomethylating agent–based regimens in older AML patients, enabling effective treatment for those ineligible for intensive chemotherapy.
AML Clinical Trial Design
Developed rigorous endpoints and statistical frameworks for AML trials, improving reproducibility and cross-trial comparisons in a notoriously heterogeneous disease.
Representative Works 代表性著作
Acute myeloid leukemia in adults
The Lancet (2006)
Comprehensive review defining modern AML management principles and treatment stratification that influenced guidelines worldwide.
Low-dose ara-C in AML: a reassessment
Leukemia (2007)
Reassessed the role of low-dose cytarabine and informed selection of patients most likely to benefit from non-intensive regimens.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Naval Daver
The University of Texas MD Anderson Cancer Center
Courtney DiNardo
The University of Texas MD Anderson Cancer Center
Gail Roboz
Weill Cornell Medicine / NewYork-Presbyterian Hospital
关注 伊利胡·埃斯蒂 的研究动态
Follow Elihu Estey's research updates
留下邮箱，当我们发布与 Elihu Estey（Fred Hutchinson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment